The University of Southampton
University of Southampton Institutional Repository

Elucidation of drug metabolite structural isomers using molecular modeling coupled with ion mobility mass spectrometry.

Elucidation of drug metabolite structural isomers using molecular modeling coupled with ion mobility mass spectrometry.
Elucidation of drug metabolite structural isomers using molecular modeling coupled with ion mobility mass spectrometry.
Ion mobility-mass spectrometry (IM-MS) in combination with molecular modelling offers the potential for small molecule structural isomer identification by measurement of their gas phase collision cross sections (CCSs). Successful application of this approach to drug metabolite identification would facilitate resource reduction, including animal usage, and may benefit other areas of pharmaceutical structural characterisation including impurity profiling and degradation chemistry. However, the conformational behaviour of drug molecules and their metabolites in the gas phase is poorly understood. Here the gas phase conformational space of drug and drug-like molecules has been investigated as well as the influence of protonation and adduct formation on the conformations of drug metabolite structural isomers. The use of CCSs, measured from IM-MS and molecular modelling information, for the structural identification of drug metabolites has also been critically assessed. Detection of structural isomers of drug metabolites using IM-MS is demonstrated and, in addition, a molecular modelling approach has been developed offering rapid conformational searching and energy assessment of candidate structures which agree with experimental CCSs. Here it is illustrated that isomers must possess markedly dissimilar CCS values for structural differentiation, the existence and extent of CCS differences being ionization state and molecule dependent. The results present that IM-MS and molecular modelling can inform on the identity of drug metabolites and highlight the limitations of this approach in differentiating structural isomers.
0003-2700
2273–2280
Reading, Eamonn
62fed933-f867-4c72-89e7-83aea573a836
Munoz-Muriedas, Jordi
85b1b025-be57-4ff0-9d9b-96d8e9e296c8
Roberts, Andrew D
32d9e53a-1173-4a62-b074-f7f5a1a32904
Dear, Gordon J
66afac91-7f5f-4519-bac9-dae2c3bd902e
Robinson, Carol V
a23ad585-fdc3-4574-a543-19e9b1782b0a
Beaumont, Claire
a354f995-c7ae-442e-9df2-25b7ef166ec1
Reading, Eamonn
62fed933-f867-4c72-89e7-83aea573a836
Munoz-Muriedas, Jordi
85b1b025-be57-4ff0-9d9b-96d8e9e296c8
Roberts, Andrew D
32d9e53a-1173-4a62-b074-f7f5a1a32904
Dear, Gordon J
66afac91-7f5f-4519-bac9-dae2c3bd902e
Robinson, Carol V
a23ad585-fdc3-4574-a543-19e9b1782b0a
Beaumont, Claire
a354f995-c7ae-442e-9df2-25b7ef166ec1

Reading, Eamonn, Munoz-Muriedas, Jordi, Roberts, Andrew D, Dear, Gordon J, Robinson, Carol V and Beaumont, Claire (2016) Elucidation of drug metabolite structural isomers using molecular modeling coupled with ion mobility mass spectrometry. Analytical Chemistry, 2273–2280. (doi:10.1021/acs.analchem.5b04068).

Record type: Article

Abstract

Ion mobility-mass spectrometry (IM-MS) in combination with molecular modelling offers the potential for small molecule structural isomer identification by measurement of their gas phase collision cross sections (CCSs). Successful application of this approach to drug metabolite identification would facilitate resource reduction, including animal usage, and may benefit other areas of pharmaceutical structural characterisation including impurity profiling and degradation chemistry. However, the conformational behaviour of drug molecules and their metabolites in the gas phase is poorly understood. Here the gas phase conformational space of drug and drug-like molecules has been investigated as well as the influence of protonation and adduct formation on the conformations of drug metabolite structural isomers. The use of CCSs, measured from IM-MS and molecular modelling information, for the structural identification of drug metabolites has also been critically assessed. Detection of structural isomers of drug metabolites using IM-MS is demonstrated and, in addition, a molecular modelling approach has been developed offering rapid conformational searching and energy assessment of candidate structures which agree with experimental CCSs. Here it is illustrated that isomers must possess markedly dissimilar CCS values for structural differentiation, the existence and extent of CCS differences being ionization state and molecule dependent. The results present that IM-MS and molecular modelling can inform on the identity of drug metabolites and highlight the limitations of this approach in differentiating structural isomers.

This record has no associated files available for download.

More information

Published date: 11 January 2016

Identifiers

Local EPrints ID: 479122
URI: http://eprints.soton.ac.uk/id/eprint/479122
ISSN: 0003-2700
PURE UUID: 79af7611-55cb-4d02-911f-84c3ebb6823b
ORCID for Eamonn Reading: ORCID iD orcid.org/0000-0001-8219-0052

Catalogue record

Date deposited: 20 Jul 2023 16:36
Last modified: 17 Mar 2024 04:19

Export record

Altmetrics

Contributors

Author: Eamonn Reading ORCID iD
Author: Jordi Munoz-Muriedas
Author: Andrew D Roberts
Author: Gordon J Dear
Author: Carol V Robinson
Author: Claire Beaumont

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×